0001611930-14-000001.txt : 20140702 0001611930-14-000001.hdr.sgml : 20140702 20140702135203 ACCESSION NUMBER: 0001611930-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140702 DATE AS OF CHANGE: 20140702 EFFECTIVENESS DATE: 20140702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEUS BIOAG HOLDINGS, LLC CENTRAL INDEX KEY: 0001611930 IRS NUMBER: 465488210 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-220265 FILM NUMBER: 14955583 BUSINESS ADDRESS: STREET 1: 200 CONTINENTAL BLVD, SUITE 301 CITY: EL SEGUNDO STATE: CA ZIP: 90245 BUSINESS PHONE: (800)327-6012 MAIL ADDRESS: STREET 1: 200 CONTINENTAL BLVD, SUITE 301 CITY: EL SEGUNDO STATE: CA ZIP: 90245 D 1 primary_doc.xml X0707 D LIVE 0001611930 PROTEUS BIOAG HOLDINGS, LLC 200 CONTINENTAL BLVD, SUITE 301 EL SEGUNDO CA CALIFORNIA 90245 (800)327-6012 DELAWARE None None Limited Liability Company true 2014 Anthony Michaels 200 Continental Blvd., Suite 301 El Segundo CA CALIFORNIA 90245 Director Promoter Issuer is managed by Proteus Environmental Technologies, LLC, a California limited liability company (PET). PET was the primary founder and organizer of Issuer's business. Person named above is also Managing Director of PET. James Rhodes 200 Continental Blvd., Suite 301 El Segundo CA CALIFORNIA 90245 Director Promoter Person named above is also Managing Director of PET. Zack Porter 200 Continental Blvd., Suite 301 El Segundo CA CALIFORNIA 90245 Director Promoter Person named above owns an equity interest in PET. Albert Pleus 1541 South Beretania Street, Suite 306 Honolulu HI HAWAII 96826 Director Douglas Rosenberg 1541 South Beretania Street, Suite 306 Honolulu HI HAWAII 96826 Director Investing Not Applicable 06b false 2014-06-19 true true true true true Issuer was founded with the purpose of acquiring and holding a controlling interest in a privately owned enterprise (whose identity Issuer desires to protect). Issuer used the proceeds from the first sale of this offering to acquire such interest. 0 25105600 6030000 19075600 In addition to acquiring the interest referenced in Item 10, Issuer has the contractual right to invest an additional $20 Million in the acquired entity. The size of the offering noted above is accordingly estimated. false 3 0 0 0 false PROTEUS BIOAG HOLDINGS, LLC Anthony F. Michaels Anthony F. Michaels Managing Director, Issuer's Manager 2014-07-02